✦ LIBER ✦

3.12.1 WHAT ARE THE PITFALLS OF CLINICAL TRIALS IN PARKINSON'S DISEASE?

✍ Scribed by A.D. Korczyn

Book ID: 117755087
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 50 KB
Volume: 18
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(11)70719-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Are high doses of carbidopa a concern? A

Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease

✍ Lissa S. Brod; Jason L. Aldred; John G. Nutt 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

The solvable problem of racial under-rep

The solvable problem of racial under-representation in Parkinson's disease clinical trials

✍ Derry Ridgway 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

AGE BIAS IN CLINICAL TRIALS OF PARKINSON

AGE BIAS IN CLINICAL TRIALS OF PARKINSON'S DISEASE TREATMENT

✍ Anoja Rajapakse; Senaka Rajapakse; Jeremy Playfer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Clinical trials in pressure ulcers - Wha

Clinical trials in pressure ulcers - What are the challenges?

✍ Nixon, J. 📂 Article 📅 2005 🏛 Elsevier 🌐 English ⚖ 830 KB

What are the four phases of clinical res

What are the four phases of clinical research trials?

✍ Sedgwick, P. 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 206 KB

Impact of placebo assignment in clinical

Impact of placebo assignment in clinical trials of Parkinson's disease

✍ Christopher G. Goetz; Kimberly Janko; Lucy Blasucci; Jean A. Jaglin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## Abstract Informed consent procedures in placebo‐controlled trials are developed to ensure that subjects entering studies clearly understand the possibility of placebo assignment. The extent of patient understanding and the impact of learning that they were assigned placebo treatment have not bee